Oral Antiplatelet Therapy After Acute Coronary Syndrome: A Review (vol 325, pg 1545, 2021)

被引:1
|
作者
Kamran, H.
Jneid, H.
Kayani, W. T.
机构
来源
关键词
D O I
10.1001/jama.2021.9484
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:190 / 190
页数:1
相关论文
共 50 条
  • [1] Oral Antiplatelet Therapy After Acute Coronary Syndrome: A Review
    Kamran, Hassan
    Jneid, Hani
    Kayani, Waleed T.
    Virani, Salim S.
    Levine, Glenn N.
    Nambi, Vijay
    Khalid, Umair
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 325 (15): : 1545 - 1555
  • [2] Acute Pancreatitis: A Review (vol 325, pg 382, 2021)
    Mederos, M. A.
    Reber, H. A.
    Girgis, M. D.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 325 (23): : 2405 - 2405
  • [3] Oral antiplatelet therapy in the treatment of acute coronary syndrome
    Yalcin, Ridvan
    [J]. TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, 2013, 41 : 4 - 11
  • [4] Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome
    Alexander, John H.
    Lopes, Renato D.
    James, Stefan
    Kilaru, Rakhi
    He, Yaohua
    Mohan, Puneet
    Bhatt, Deepak L.
    Goodman, Shaun
    Verheugt, Freek W.
    Flather, Marcus
    Huber, Kurt
    Liaw, Danny
    Husted, Steen E.
    Lopez-Sendon, Jose
    De Caterina, Raffaele
    Jansky, Petr
    Darius, Harald
    Vinereanu, Dragos
    Cornel, Jan H.
    Cools, Frank
    Atar, Dan
    Luis Leiva-Pons, Jose
    Keltai, Matyas
    Ogawa, Hisao
    Pais, Prem
    Parkhomenko, Alexander
    Ruzyllo, Witold
    Diaz, Rafael
    White, Harvey
    Ruda, Mikhail
    Geraldes, Margarida
    Lawrence, Jack
    Harrington, Robert A.
    Wallentin, Lars
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (08): : 699 - 708
  • [5] Oral Antiplatelet Therapy for Secondary Prevention of Acute Coronary Syndrome
    Berger, Jeffrey S.
    [J]. AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2018, 18 (06) : 457 - 472
  • [6] Oral Antiplatelet Therapy for Secondary Prevention of Acute Coronary Syndrome
    Jeffrey S. Berger
    [J]. American Journal of Cardiovascular Drugs, 2018, 18 : 457 - 472
  • [7] Considerations in patients receiving oral antiplatelet therapy after acute coronary syndrome and percutaneous coronary intervention
    Roffman, David S.
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2010, 67 (15) : S18 - S24
  • [8] Combined antiplatelet and novel oral anticoagulant therapy after acute coronary syndrome: is three a crowd?
    Verheugt, Freek W. A.
    [J]. EUROPEAN HEART JOURNAL, 2013, 34 (22) : 1618 - 1620
  • [9] Abbreviated dual antiplatelet therapy after acute coronary syndrome
    Steiner-Gager, Gloriam M.
    Siller-Matula, Jolanta M.
    [J]. LANCET, 2024, 403 (10439): : 1823 - 1825
  • [10] Oral antiplatelet therapy after acute coronary syndrome and percutaneous coronary intervention: Balancing efficacy and bleeding risk
    Spinler, Sarah A.
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2010, 67 (15) : S7 - S17